1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session,...

47
1 Monitoring and Evaluation: HIV/AIDS Programs
  • date post

    20-Dec-2015
  • Category

    Documents

  • view

    215
  • download

    0

Transcript of 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session,...

Page 1: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

1

Monitoring and Evaluation: HIV/AIDS Programs

Page 2: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

2

Learning Objectives

At the end of this session, participants will be able to:• Identify M&E implications of the global HIV/AIDS

program context• Identify M&E and information systems implications

of the HIV/AIDS program environment• Apply basic M&E concepts to an HIV/AIDS

program component• Explain the implications of broadened HIV/AIDS

programs, particularly treatment scale up, for monitoring program impact

Page 3: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

3

Context

Page 4: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

4

Global Summary of the HIV/AIDS

Epidemic December 2004

Number of people living with HIV/AIDS Total 39.4 million (35.9 - 44.3 million) Adults 37.2 million (33.8 - 41.7 million)

Children under 15 years 2.2 million (2.0 - 2.6 million)

People newly infected with HIV in 2003 Total 4.9 million (4.3 - 6.4 million)

Adults 4.3 million (3.7 – 5.7 million)

Children under 15 years 640 000 (570 000 – 750 000)

AIDS deaths in 2003 Total 3.1 million (2.8 – 3.5 million)

Adults 2.6 million (2.3 – 2.9 million)

Children under 15 years 510 000 (460,000 – 600,000)

Page 5: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

5

Global Action to Address the HIV/AIDS Epidemic

2000 2001 2003 2004

Word Bank multi-sectoral AIDS Project (MAP)

United Nations General Assembly Special Session on

AIDS (UNGASS)

Global Fund for AIDS, Malaria, and Tuberculosis

U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)

World Health Organization's call to provide treatment to 3 million people by 2005 (WHO 3x5)

(Announced December 1, 2003)

Page 6: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

6

GOALS: Global

• Millennium Development Goal 6: Combat HIV/AIDS, malaria, and other diseases

Target 7: Have halted by 2015 and begun to reverse the spread of HIV/AIDS

• WHO 3 by 5 Goal: Universal access to antiretroviral therapy for all living with HIV/AIDS

Target: Treating 3 million people by 2005

Page 7: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

7

Goals: US Presidents Emergency Plan

• Prevention of 7 million new infections

• Treat 2 million HIV-infected people

• Care for 10 million HIV-infected individuals and AIDS orphans

Page 8: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

8

What Are the Goals of HIV/AIDS Programs?

• Prevent new HIV infections

• Extend and improve life for those already infected with HIV

• Mitigate the social and economic impacts of the epidemic

Page 9: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

9

Key HIV/AIDS Program Areas

Prevention• Behavior Change and Communication

– e.g. sexual behavior, condom use, injecting drug use (IDU) behaviors• Medical Interventions

– e.g. PMTCT, VCT, blood safety, universal precautions, STI treatment etc.Care and Treatment

• Care and support to PLWHA and their families• Prophylaxis and treatment of opportunistic infections (including tuberculosis)• Treatment with antiretroviral therapy (ART)

Impact Mitigation• Support to Orphans and Vulnerable Children (OVC)• Reduction of stigma and discrimination• Addressing gender disparities

Page 10: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

10

M&E Implications

Page 11: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

11

M&E Implications

• High emphasis on accountability– Mandatory’ reporting on international indicators (MDG

and UNGASS)– Donor-reporting requirements linked to large influx of

money

• Drive toward standardization

Page 12: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

12

The Three Ones: Principles for the coordination of national AIDS responses

• One agreed-upon HIV/AIDS Action Framework that provides the basis for coordinating the work of all partners.

• One national AIDS authority, with a broad-based multi-sectoral mandate.

• One agreed-upon country-level monitoring and evaluation system

Source: UNAIDS. 2004. Commitment to principles for concerted AIDS action at country level

Page 13: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

13

M&E Challenges

• Complex multi-sectoral M&E plans

• Wide range of information needed

• Different approaches needed in concentrated versus generalized epidemics

• Each HIV/AIDS program component has specific M&E needs and challenges

Page 14: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

14

M&E Challenges I

ALL COMPONENTS

•Rapid scale-up of new/routine systems

•Denominators – identifying eligible people

•Double counting in service statistics

Page 15: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

15

M&E Challenges I

PREVENTION

•Quality of reporting of sensitive behaviors

•Identifying size of most-at-risk population

VCT & PMTCT

•Measuring impact

•Quality of services

•Service cascade

Page 16: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

16

M&E Challenges II

CARE AND SUPPORT•Little M&E experience •Often community-based•Minimum care standards•Integration with TB-tracking referrals

ARV•Patient-level tracking systems•Adherence

Page 17: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

17

M&E Challenges III

OVC•Little M&E experience•Often community-based•Minimum package of services•Psychosocial support measurement •Ethical & methodological issues in data collection

STIGMA & DISCRIMINATION•Definitions•Measurement tools – validity in different contexts•Selection bias – only disclosed PLWHA observed

Page 18: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

18

Applying General M&E Principles to HIV/AIDS Programs

Page 19: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

19

General M&E Principles

• Determine how data are to be used• Prepare M&E Plan

– M&E Framework– Indicators– Data sources and data-collection schedule– Evaluation-design / targeted-evaluations needs– Data reporting and utilization plan

• Implement M&E Plan• Use data for program decision-making and reporting

Page 20: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

20

Information for Decision Making

• Global Level: Are we achieving global goals?• National Level: What should be the national policy on

PMTCT?• Program Level: Are we distributing services to meet the

need?• Facility Level: Are we providing enough services to meet

the need?• Provider Level: What is quality of a care for this patient?• Community Level: What are we doing as a community to

meet the need?• Individual Level: Where should I get treatment?

Page 21: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

21

Frameworks for HIV/AIDS Programs

• Different types of frameworks can be used (e.g. Results framework, log frame)

• Different, inter-related frameworks for different program areas (e.g. VCT, PMTCT, care and support) likely to be needed for a comprehensive program.

• Output of one program activity may be the input to another

• HIV/AIDS frameworks based on relevant documents such as a national AIDS strategy.

Page 22: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

22

HIV/AIDS Indicators

Program-level, National- and Global-level Indicators (Guides/Sources)

First-generation• 2000: General HIV/AIDS programsSecond-generation• 2004: HIV/AIDS Care and Support• 2004: Prevention of HIV in infants and young children (PMTCT)• 2004: HIV/AIDS programmes for young people • 2005 update: UNGASS (Millennium Development Goals)• 2005: ARV • 2000-2005: All UNAIDS and partner HIV/AIDS guides• To be released: OVC program guide (FHI), Concentrated

Epidemics M&E Guide, and revised GFATM Toolkit (2005/06)

Page 23: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

Information sources for HIV/AIDS M&E

• Document review and key informant interviews– National Composite Policy Index– AIDS Program Effort Index

• Routine program information– Annual condom sales– Providers trained in VCT etc.

• Routine health information systems– No. client visits for VCT etc.– ARV drugs distributed etc.

• Medical records/patient tracking systems– ART adherence– No. patients on ART

• PLACE (Priorities for Local AIDS Control Efforts)– Identification and characteristics of sites where risk behaviors take place– Sexual partnership formation at sites

Page 24: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

Information sources for HIV/AIDS M&E

• Facility surveys– Coverage of HIV/AIDS services (facility-based)– Readiness to provide quality HIV/AIDS services– Appropriate STI management

• General Population surveys– Sexual behavior – HIV seroprevalence

• Targeted Population Surveys/Behavioral Surveillance Surveys– Sexual and other risk behaviors – HIV seroprevalence

• Surveillance– HIV seroprevalence

• Vital Registration– AIDS mortality

Page 25: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

25

Information Storage: CRIS

Country Response Information System• Purpose:

To enable the systematic – storage– analysis– retrieval– dissemination of collected information on a country’s response to HIV/AIDS

• Structure: Integrated system with 3 modules– Indicator – Project / resource tracking– Research Inventory

Page 26: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

Reporting Schematic

Linkages 1 March 15, 2005

National AIDS Council

NASCOP Intervention-specific databases

Persons with HIV/AIDS

Health Facility offering HIV/AIDS related services Community-based

organization offering HIV/AIDS related services

Households affected by HIV/AIDS

Orphans and vulnerable children

DASCO

CACC

DTC

PASCO

Community-Based Routine Information System

HMIS

Routine Program Information (e.g., mass media, training, etc…)

Periodic surveys (DHS, SPA, BSS)

ANC surveillance

Research

Information from Line Ministries

CRIS, MDG, UNAIDS Stakeholders (e.g., funders, implementers, users)

NASCOP: National AIDS and STI Control Program, MOH PASCO: Provincial AIDS and STI Control Officer DASCO: District ASCO DAT: District AIDS Team CACC: Constituency ACC

Reporting from National AIDS Council Information flow

General Population

ARV, OI prophylaxis and treatment

VCT, PMTCT, PEP, STI

Page 27: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

27

EXAMPLE: VCT

Page 28: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

28

Illustrative Questions for VCT programs

• Are VCT services being provided as planned?• Do services meet minimum quality standards?• Is utilization of services increasing?• Are there reductions in riskier behavior (among those

seeking services)?• Are there increases in use of care, support, and treatment

services (among those seeking services)?

Page 29: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

29

Page 30: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

30

Illustrative Process and Output Indicators

• Number of people trained in providing VCT according to national and international standards

• Number of people who receive counseling (by sex) • Number of people who receive testing (by sex)• Number of clients who test positive for HIV• Number of HIV+ clients referred to treatment, care, and

support services

Page 31: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

31

Percentage of Facilities Providing VCT Services

15

11

0

2

4

6

8

10

12

14

16

%

Ghana (n=428) Uganda (n=226)

Source: 2002 Ghana HIV Service Provision Assessment and 2002 Uganda HIV Service Provision Assessment

Page 32: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

32

Percentage of VCT Sites With Selected Inputs for Quality Counseling

2

81

19

21

39

2

47

All items

Condoms in facility

Condoms at service site

Stop AIDS poster

Visual aids for HIV/AIDS

Guidelines

Visual and auditory privacy

Source: 2002 Ghana HIV Service Provision Assessment

Percent

Page 33: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

33

Percentage of VCT Sites With Selected Inputs for Quality Counseling

96

52

65

62

63

78

Trained staff

Trained lab technician

Client register

HIV test kits

Visual aids for VCT

VCT guidelines

Percent

Source: 2002 Uganda HIV Service Provision Assessment

Page 34: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

34

Illustrative Outcome Indicators

• Percentage of people in the community who know about the VCT services

• Proportion of people counseled and tested who report positive behavior change to avoid HIV infection/transmission

• Proportion of people tested and found to be HIV+ who report positive or negative reactions from others

Page 35: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

35

HIV testing among women in Zambia

05

101520253035404550556065707580

Urban Rural All

Desires to be tested Knows source of testing Has been tested

Source: 2001 Zambia DHS

Page 36: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

36

HIV testing among men and women in Zambia

05

1015202530354045505560657075

Men Women

Desires to be tested Knows source of testing Has been tested

Source: 2001 Zambia DHS

Page 37: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

37

HIV testing experience among sentinel groups in Zambia

0

5

10

15

20

25

30

35

Female sex workers Male long-distance truck drivers

VCTEver tested

Source: BSS, Zambia 2000

Page 38: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

38

• Multi-center randomized trial: 1995-1997

• Three sites: Kenya (N=1515), Tanzania (N= 1427) & Trinidad (N=1357)

• Randomized to receive VCT (N=2152) or Health Information (N=2141)

• Traced and interviewed at 6 & 12 months

• Cross-over at 6 months so that the original Health Information group now had access to VCT

Multi-centre study Design of the VCT Efficacy Study

Page 39: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

39

Multi-centre study Unprotected intercourse with non-primary partners decreased significantly more among VCT participants

percent

0

10

20

30

40

HI Males

VCTMales

HIFemales

VCTFemales

Baseline 6 Months 12 Months

Page 40: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

40

Multi-centre study: Unprotected intercourse with commercial sexual partners decreased significantly more among VCT participants

0

2

4

6

8

10

12

14

HI males

VCT males

HIfemales

VCTfemales

Overall HI

OverallVCT

Baseline

6 months

Page 41: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

41

HIV Program Impact

Page 42: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

42

Incidence vs. Prevalence

• Incidence = number of new infections in a time period

susceptible population (HIV negative) in the time period

• Prevalence = number of infected people at a given point in time

total population (HIV negative & HIV positive) at that point in time

Page 43: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

43

Prevalence, the faucet and sink…

Number of HIV infected people

New HIV Infections

Deaths

Page 44: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

44

Impacts Indicators

• Prevent new HIV infections– Percentage of young people aged 15-24 who are HIV-infected (UNGASS and

Millennium Development Goal)– Percentage of HIV-infected infants born to HIV-infected mothers (UNGASS)

• Extend and improve life for those already infected with HIV– AIDS incidence and prevalence– Quality of life measures – Case fatality rate for HIV/AIDS– Proportion of mortality attributed to AIDS– General population life expectancy

• Mitigate the social and economic impacts of the epidemic– Gross national product or other economic indicators– Infant and child mortality rates

Page 45: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

45

Impacts: HIV sero-prevalence among 20-24 year old antenatal women in Uganda: 1990-2001

0

5

10

15

20

25

30

35

40

Nsambya Fort Portal Mbale

1990 1991 1992 1993 1994 1995 1996 1997 19981999 2000 2001

Source: STD/AIDS Control Programme, Ministry of Health, Uganda 2002

Page 46: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

46

Impacts: HIV prevalence estimates based on ANC sentinel-site surveillance vs. estimates based on population surveys

Estimated HIV Prevalence in General Population Aged 15-49

05

10152025

Kenya Mali SouthAfrica

Zambia

Pe

rce

nta

ge

ANC SurveillancePopulation Survey

Sources: Boerma, et. al. 2003; Central Bureau of Statistics 2004; Republic of Kenya 2001

Page 47: 1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.

47

SAVVY - Sample Vital Registration with Verbal Autopsy

• A package:– “Sample vital registration” conducted in surveillance

communities– “Verbal autopsy” conducted as an interview with the family of the

deceased to ascertain the likely cause of death

• Purpose is – to provide measurement of vital events when alternative sources

(vital registration) are not available or not complete– To provide information on the cause of death when death

certificates may not be accurate

• May be used to monitor AIDS related deaths, use of health services, etc.